Lowe H, McMahon D J, Rubin M R, Bilezikian J P, Silverberg S J
Department of Medicine, PH 8W-864, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032, USA.
J Clin Endocrinol Metab. 2007 Aug;92(8):3001-5. doi: 10.1210/jc.2006-2802. Epub 2007 May 29.
Patients with elevated PTH and consistently normal serum calcium levels, in whom secondary causes of hyperparathyroidism have been excluded, may represent the earliest presentation of primary hyperparathyroidism (PHPT).
The objective of the study was to characterize patients with normocalcemic PHPT referred to a bone disease unit.
This was a longitudinal cohort study.
Ambulatory patients were referred to the metabolic bone disease unit.
The study population included 37 patients [aged 58 yr, range 32-78; 95% female; serum calcium, 9.4 +/- 0.1 (sem) mg/dl (2.3 +/- 0.02 mmol/liter), reference range, 8.5-10.4 (2.1-2.6 mmol/liter); PTH, 93 +/- 5 pg/ml].
Interventions included yearly (median 3 yr; range 1-8 yr) physical examination, biochemical indices, and bone mineral density (BMD).
We measured the development of features of PHPT.
Evaluation for classical features of PHPT revealed a history of kidney stones in five (14%), fragility fractures in four (11%), and osteoporosis in 57% [spine (34%), hip (38%), and/or distal one third radius (28%)]. BMD did not show preferential bone loss at the distal one third radius (T scores: spine, -2.00 +/- 0.25; hip, -1.84 +/- 0.18; one third radius, -1.74 +/- 0.22). Further signs of PHPT developed in 40% (seven hypercalcemia; one kidney stone; one fracture; two marked hypercalciuria; six had >10% BMD loss at one or more site(s) including four patients developing World Health Organization criteria for osteoporosis). Seven patients (three hypercalcemic, four persistently normocalcemic) underwent successful parathyroidectomy.
Patients seen in a referral center with normocalcemic hyperparathyroidism have more substantial skeletal involvement than is typical in PHPT and develop more features and complications over time. These patients may represent the earliest form of symptomatic, rather than asymptomatic, PHPT.
甲状旁腺激素(PTH)升高但血清钙水平持续正常的患者,若已排除继发性甲状旁腺功能亢进的病因,则可能代表原发性甲状旁腺功能亢进症(PHPT)的最早表现形式。
本研究的目的是对转诊至骨病科的血钙正常的PHPT患者进行特征描述。
这是一项纵向队列研究。
门诊患者被转诊至代谢性骨病科。
研究人群包括37例患者[年龄58岁,范围32 - 78岁;95%为女性;血清钙9.4±0.1(标准误)mg/dl(2.3±0.02 mmol/L),参考范围8.5 - 10.4(2.1 - 2.6 mmol/L);PTH 93±5 pg/ml]。
干预措施包括每年(中位时间3年;范围1 - 8年)进行体格检查、生化指标检测和骨密度(BMD)检测。
我们对PHPT特征的发展情况进行了测量。
对PHPT典型特征的评估显示,5例(14%)有肾结石病史,4例(11%)有脆性骨折病史,57%有骨质疏松[脊柱(34%)、髋部(38%)和/或桡骨远端三分之一处(28%)]。骨密度在桡骨远端三分之一处未显示出优先的骨质流失(T值:脊柱,-2.00±0.25;髋部,-1.84±0.18;桡骨远端三分之一处,-1.74±0.22)。40%的患者出现了PHPT的进一步体征(7例高钙血症;1例肾结石;1例骨折;2例明显高钙尿症;6例在一个或多个部位骨密度损失>10%,其中4例符合世界卫生组织骨质疏松症标准)。7例患者(3例高钙血症患者,4例血钙持续正常患者)接受了成功的甲状旁腺切除术。
在转诊中心见到的血钙正常的甲状旁腺功能亢进患者,其骨骼受累程度比典型的PHPT更严重,且随着时间的推移会出现更多特征和并发症。这些患者可能代表有症状而非无症状的PHPT的最早形式。